Drug intelligence / Profile preview

lornoxicam + paracetamol + thiocochicoside

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

This drug is a fixed-dose combination of three active pharmaceutical ingredients: - **Lornoxicam** is a non-steroidal anti-inflammatory drug (NSAID) from the oxicam class, which works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. - **Paracetamol** (also known as acetaminophen) is an analgesic and antipyretic that acts primarily in the central nervous system to inhibit prostaglandin synthesis, providing pain relief and fever reduction. - **Thiocochicoside** is a muscle relaxant that acts on the central nervous system, likely through modulation of GABA-A receptors or glycine receptors, leading to reduced muscle spasms. The combination provides multimodal management for musculoskeletal pain conditions by addressing inflammation, nociceptive pain, and muscle spasm. It is typically used for acute painful musculoskeletal disorders such as back pain, sprains, joint pain with associated muscle spasm, arthritis flare-ups with significant muscular involvement, or post-operative musculoskeletal discomfort.

02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GABRR (GABA-A receptor subunit rho)Glycine receptorTRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on lornoxicam + paracetamol + thiocochicoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lornoxicam + paracetamol + thiocochicoside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call